RG
ALXN
Rathbones Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-1,090
| Closed | -$200K | – | 441 |
|
2021
Q2 | $200K | Buy |
+1,090
| New | +$200K | ﹤0.01% | 402 |
|
2021
Q1 | – | Sell |
-2,790
| Closed | -$436K | – | 427 |
|
2020
Q4 | $436K | Hold |
2,790
| – | – | 0.01% | 293 |
|
2020
Q3 | $319K | Hold |
2,790
| – | – | 0.01% | 302 |
|
2020
Q2 | $313K | Buy |
2,790
+130
| +5% | +$14.6K | 0.01% | 289 |
|
2020
Q1 | $239K | Hold |
2,660
| – | – | 0.01% | 270 |
|
2019
Q4 | $288K | Hold |
2,660
| – | – | 0.01% | 278 |
|
2019
Q3 | $261K | Hold |
2,660
| – | – | 0.01% | 285 |
|
2019
Q2 | $348K | Hold |
2,660
| – | – | 0.01% | 258 |
|
2019
Q1 | $360K | Hold |
2,660
| – | – | 0.01% | 246 |
|
2018
Q4 | $259K | Hold |
2,660
| – | – | 0.01% | 270 |
|
2018
Q3 | $370K | Buy |
2,660
+100
| +4% | +$13.9K | 0.01% | 237 |
|
2018
Q2 | $318K | Buy |
2,560
+520
| +25% | +$64.6K | 0.01% | 239 |
|
2018
Q1 | $227K | Hold |
2,040
| – | – | 0.01% | 278 |
|
2017
Q4 | $244K | Hold |
2,040
| – | – | 0.01% | 276 |
|
2017
Q3 | $286K | Hold |
2,040
| – | – | 0.01% | 252 |
|
2017
Q2 | $248K | Buy |
2,040
+50
| +3% | +$6.08K | 0.01% | 265 |
|
2017
Q1 | $241K | Buy |
1,990
+100
| +5% | +$12.1K | 0.01% | 273 |
|
2016
Q4 | $231K | Hold |
1,890
| – | – | 0.01% | 267 |
|
2016
Q3 | $232K | Hold |
1,890
| – | – | 0.01% | 274 |
|
2016
Q2 | $221K | Buy |
1,890
+50
| +3% | +$5.85K | 0.01% | 265 |
|
2016
Q1 | $256K | Hold |
1,840
| – | – | 0.02% | 239 |
|
2015
Q4 | $308K | Hold |
1,840
| – | – | 0.02% | 229 |
|
2015
Q3 | $288K | Hold |
1,840
| – | – | 0.02% | 240 |
|
2015
Q2 | $333K | Buy |
1,840
+200
| +12% | +$36.2K | 0.02% | 239 |
|
2015
Q1 | $284K | Hold |
1,640
| – | – | 0.02% | 254 |
|
2014
Q4 | $303K | Hold |
1,640
| – | – | 0.02% | 249 |
|
2014
Q3 | $272K | Hold |
1,640
| – | – | 0.02% | 252 |
|
2014
Q2 | $256K | Hold |
1,640
| – | – | 0.02% | 250 |
|
2014
Q1 | $249K | Buy |
+1,640
| New | +$249K | 0.02% | 240 |
|
2013
Q4 | – | Sell |
-1,965
| Closed | -$228K | – | 269 |
|
2013
Q3 | $228K | Buy |
+1,965
| New | +$228K | 0.03% | 231 |
|